BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Cancer / Oncology

Alphamab Oncology and CSPC Dose First Patient in Phase III Trial of JSKN003 for HER2-Positive Breast Cancer

Alphamab Oncology (Stock Code: 9966.HK) and CSPC Pharmaceutical Group Co., Ltd. ("CSPC") (Stock Code: 1093.HK) jointly announced that the first patient has...

February 28, 2025 | News

Innovent’s Ipilimumab NDA Accepted by China’s NMPA with Priority Review for MSI-H/dMMR Colon Cancer

Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality me...

February 25, 2025 | News

MGI Partners with Oncoclínicas&Co to Expand Genomic Testing and Oncology Diagnostics in Brazil

MGI Tech Co., Ltd. ("MGI"), a company committed to building core tools and technologies that drive innovation in life science, established a partnersh...

February 25, 2025 | News

Akeso, Summit Therapeutics, and Pfizer Join Forces to Advance Ivonescimab-ADC Combinations in Solid Tumor Trials

Akeso, Inc. announced that its partner on ivonescimab, Summit Therapeutics Inc. has entered into a clinical trial collaboration with Pfizer Inc...

February 25, 2025 | News

Akeso Begins Phase III Trial of Ivonescimab for First-Line Treatment of Advanced Triple-Negative Breast Cancer

Akeso, Inc. (9926.HK) ("Akeso" or the "Company") today announced the company has successfully enrolled the first patient in its multicenter, ran...

February 24, 2025 | News

Harbour BioMed and Insilico Medicine Partner to Accelerate AI-Driven Antibody Discovery

Harbour BioMed, a global biopharmaceutical company committed to the discovery, development and commercialization of novel antibody therapeutics focusing on...

February 21, 2025 | News

Nona Biosciences Partners with UAB to Advance B Cell Research Using H2L2 Harbour Mice®

Nona Biosciences, a global biotechnology company providing a total solution from "Idea to IND" (I to I™), announced a licensing agreement with ...

February 20, 2025 | News

Roche and Yemaachi Launch The African Cancer Atlas to Advance Precision Oncology Across Africa

Roche has signed as the founding partner to initiate the consortium which will generate genomic and clinical data from up to 7,500 African cancer pat...

February 19, 2025 | News

NERLYNX® Approved in Thailand for Early and Advanced HER2+ Breast Cancer Treatment

NERLYNX® (neratinib) has been approved as a single agent for the treatment of early-stage HER2+ breast cancer, and in combination with capecitab...

February 18, 2025 | News

Innovent’s IBI363 Secures Second FDA Fast Track Designation for Advanced Lung Cancer

Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures, and commercializes high-quality m...

February 17, 2025 | News

Akeso Initiates Phase 3 Trial in China for Cadonilimab as Consolidation Therapy in Advanced NSCLC

Akeso, Inc. announced the recent completion of the first patient enrollment in the Phase 3 randomized, double-blind, multicenter clinical trial (COMPASSION...

February 13, 2025 | News

Lion TCR Secures FDA Clearance for Phase 2 Trial of Pioneering mRNA TCR-T Therapy for Liver Cancer

Lion TCR announced that its mRNA-encoded T-cell receptor (TCR)-T cell therapy product Liocyx-M004 has received clearance from the U.S. Food and Drug A...

February 12, 2025 | News

Gene Solutions Introduces AI-Powered Blood Test to Transform Lung Cancer Screening in Asia

Asia is the region most impacted by lung cancer, accounting for 63.1% of newly diagnosed lung cancers and 62.9% of lung cancer deaths worldwide(1). M...

February 06, 2025 | News

Henlius Secures EU Approval for Serplulimab Expanding Global Cancer Care

Shanghai Henlius Biotech, Inc. (2696.HK) has secured a significant milestone with the European Commission (EC) approval of HANSIZHUANG (serplulimab...

February 06, 2025 | News

Stay Connected